Edesa Biotech, Inc. (EDSA): 7 insider purchases in the last two years.
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Mar 11, 2026 | Brooks Michael J Officer | 2,000 | $1.57 | $3.1K | no history |
| Mar 10, 2026 | Nijhawan Pardeep Director, Officer, TenPercentOwner | 1,000 | $6.60 | $6.6K | no history |
| Mar 6, 2026 | Nijhawan Pardeep Director, Officer, TenPercentOwner | 10,000 | $3.90 | $39.0K | no history |
| Mar 5, 2026 | Nijhawan Pardeep Director, Officer, TenPercentOwner | 10,000 | $4.26 | $42.6K | no history |
| Mar 4, 2026 | Nijhawan Pardeep Director, Officer, TenPercentOwner | 10,000 | $3.63 | $36.3K | no history |
| Mar 3, 2026 | Nijhawan Pardeep Director, Officer, TenPercentOwner | 3,000 | $2.09 | $6.3K | no history |
| Mar 2, 2026 | Nijhawan Pardeep Director, Officer, TenPercentOwner | 50,571 | $1.96 | $99.1K | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.